Clinical Trial

Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in adult patients with chronic, moderate to severe alopecia areata.
Protocol Amendment History 52 amendments
This ClinicalTrials.gov record has been amended 52 times since 2019-03-29; most recent amendment 2025-10-20.
Status change: Enrolling by Invitation → Active, Not Recruiting 2024-07-01
Status change: Recruiting → Enrolling by Invitation 2022-06-02
Status change: Active, Not Recruiting → Recruiting 2021-05-14
Status change: Recruiting → Active, Not Recruiting 2020-04-03
Trial Details
NCT Number NCT03898479
Lead Sponsor Sun Pharmaceutical Industries, Inc.
Conditions Alopecia Areata
Enrollment 1,000 participants
Start Date 2019-04-04
Primary Completion 2027-05 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-10-22